Characteristics of Young Children Hospitalized With Acute Respiratory Failure From Infection With Respiratory Syncytial Virus, SARS-CoV-2, or Both, November 2023-March 2024
- PMID: 41822373
- PMCID: PMC12978529
- DOI: 10.1093/ofid/ofag088
Characteristics of Young Children Hospitalized With Acute Respiratory Failure From Infection With Respiratory Syncytial Virus, SARS-CoV-2, or Both, November 2023-March 2024
Abstract
Background: Respiratory syncytial virus (RSV) and SARS-CoV-2 can cause acute respiratory failure in children. We compared characteristics and outcomes of children aged <2 years with respiratory failure from infection with RSV, SARS-CoV-2, or both viruses.
Methods: We used data from a US pediatric respiratory virus hospitalization surveillance network including children with ICU admission for acute respiratory failure (receiving high-flow oxygen or mechanical ventilation) with RSV and/or SARS-CoV-2 during November 2023-March 2024. Demographic, clinical characteristics, and hospitalization outcomes were stratified by a positive test for RSV, SARS-CoV-2, or both viruses, and compared using chi-squared or Kruskal-Wallis tests. Multivariable analyses assessed independent associations between outcomes and infection.
Results: Overall, 1406 children were included: 1253 (89.1%) for RSV, 105 (7.5%) for COVID-19, and 48 (3.4%) with RSV + SARS-CoV-2 detected. Children with RSV or RSV + SARS-CoV-2 had lower median ages (3.9 and 5.4 months, respectively) compared with those with SARS-CoV-2 (8.8 months; P < .001). Twenty percent of children with RSV and 43.8% with COVID-19 had an underlying medical condition. Among infants aged <1 year for whom preterm status was available, 31.5% with RSV and 50% with COVID-19 had either prematurity or a comorbidity. Children with SARS-CoV-2 were more likely to require invasive mechanical ventilation, receive vasoactive infusions, and die compared with RSV with and without SARS-CoV-2.
Conclusions: Critically ill children <2 years of age infected with SARS-CoV-2 had more severe illness presentation and outcomes and were older compared with those with RSV and RSV + SARS-CoV-2 codetection. Most children were previously healthy, highlighting the need for prevention measures.
Keywords: COVID-19; pediatric; respiratory failure; respiratory syncytial virus.
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2026.
Conflict of interest statement
Potential Conflicts of interest. A. B. M., A. B. P., A. O., A. P. P., J. A. G., J. C. C., J. M. C., K. C., K. L., L. D. Z., L. M. M., M. A. C., M. M, M. M. N., M. S. Z., R. A. N., R. M. S., S. J. G., S. L. S., S. S. B., and T. T. B.: No conflicts. A. G. R. reports grant or contract support from NIH to Boston Children's Hospital, royalties or licenses from UpToDate, consulting fees from Inotrem, Inc., payment or honoraria from ThermoFisher, Inc., and unpaid council member rolls in the International Sepsis Forum and Families Fighting Flu. B. M. C. reports grant or contract support from NIH/NHLBI and NIH/NIAID to Ann and Robert H. Lurie Children's Hospital. D. M. Z. reports grant or contract support from Columbia University and Merck to the University of Washington and Seattle Children's Research Institute and participation on a Data Safety Monitoring Board for Allovir. H. C. reports grant or contract support from NIH/NIGMS to the University of Utah and payment for expert testimony from Mortensen and Milne. J. E. S. reports grant or contract support from NIH, FDA, and the State of Missouri to Children's Mercy Kansas City, consulting fees from the Association of Professionals in Infection Control and Epidemiology, speaking honoraria from the Missouri American Academy of Pediatrics, Payment from CDC for a review panel, and participation as an advisory board member for a grant awarded to the Association of American Medical Colleges for vaccine confidence. J. R. H. reports grant or contract support from NIH/NIAID and NIH/NICHD to Minnesota Masonic Children's Hospital and unpaid participation on a Data Safety Monitoring Board. K. I. reports grant or contract support from NIH to Arkansas Children's Hospital. K. W. reports grant or contract support from NHLBI, NIH, and ASPR to University of Iowa Carver College of Medicine. M. A. S. reports grant or contract support from NIH, Cepheid, Merck to Cincinnati Children's Hospital, royalties or licenses from UpToDate, and consulting fees from Merck. M. K. reports grant or contract support from NIH to the University of Alabama and unpaid board membership on the Jefferson Board of Health, UAB Callahan, and KultureCity. NBH reports grant or contract support from Merck to Vanderbilt University Medical Center and has served as a consultant for CSL-Seqirus. S. K. reports grant or contract support from NIH, Pfizer, Moderna, Meissa, Bavarian Nordic, and Sanofi to Emory University and payment or honoraria from the American Academy of Pediatrics. T. J. C. reports grant or contract support from NIH to Columbia University Irving Medical Center. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
References
-
- Centers for Disease Control and Prevention . RSV-NET interactive dashboard. Available at: https://www.cdc.gov/rsv/php/surveillance/rsv-net.html?CDC_AAref_Val=http.... Accessed 14 February 2025.
-
- Centers for Disease Control and Prevention . Respiratory Virus Hospitalization Surveillance Network (RESP-NET). Available at: https://www.cdc.gov/resp-net/dashboard/index.html#cdc_data_surveillance_.... Accessed 22 April 2025.
-
- Curns AT, Rha B, Lively JY, et al. Respiratory syncytial virus-associated hospitalizations among children <5 years old: 2016 to 2020. Pediatrics 2024; 153:e2023062574. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
